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PROFORMA 
Case No.:     IP. No.:    Outcome: 
Name:      Religion:    Informant: 
Age:      Occupation:    Father:   
DOA: 
Sex:          Mother:   
DOD: 
Address: 
CHIEF COMPLAINTS WITH DURATION 
• Fever 
• Loose stools 
• Vomiting 
• Pain abdomen 
• Blood loss 
• Skin bleeds (petechiae, purpura) 
• Cough 
• Chest pain 
• Headache 
• Convulsions 
• Sensorium 
• Convulsions 
• Ear discharge 
• Burning micturation 
• Pyoderma 
• Pain in joint 
• Palpitation 
• Cyanosis 
• Cold extremities 
• H/O suck rest suck cycle 
• H/o drug intake 
• H/o exposure to allergen 
• H/o scorpion sting 
• H/o snakebite 
• H/o polyuria, polydypsia, weight loss 
• H/o abrupt stopping of steroids 
• H/o head injury 
• H/o loss of weight, loss of appetite 
PAST HISTORY 
FAMILY HISTORY 
BIRTH HISTORY: Antenatal history 
Natal history 
Post-natal history 
Developmental History: Normal / Delayed  
 
General physical examination 
Anthropometry: Present Expected Comment 
Weight (kg): 
Length/height: 
HC: 
CC: 
MAC: 
Normal/grade: 1/2/3/4 IAP classification 
Vitals:  
HR (bpm) 0 hrs 12 hrs 24 hrs 48 hrs 
Pulse  
RR/min 
BP (mm of Hg) 
Temp (of) 
CFT: 
Urine output: 
GCS: 
Head to toe examination: 
Head 
Eye:      Ear: 
Mouth: 
Neck:      Hydration status: 
Upper limb: 
Lower limb: 
Systemic examination 
Cardiovascular system: 
Inspection:  Apical impulse 
Precordial bulge 
Other pulsation: 
Palpation:  Apex beat 
Thrill 
Parasternal heave- 
Palpable p2 
Percussion 
Auscultation  Mitral area: 
Tricuspid area: 
Pulmonary area: 
Aortic area: 
Per abdomen 
Inspection: 
Palpation: 
Percussion: 
Auscultation: 
 
Respiratory system: Inspection:  Trachea: 
B/L chest movements: 
Dilated veins: 
Palpation: 
Percussion: 
Auscultation: Bilateral air entry 
Breath sounds: 
Added sounds: 
Central nervous system 
Higher mental function: GCS: 
Cranial nerves: 
Motor system: Bulk: 
Tone: 
Power: 
Reflexes:  Superficial 
Deep 
Gait: 
Involuntary movements: 
Sensory system 
s/o meningeal irritation: 
s/o cerebellar dysfunction: 
Diagnosis:    Functional category:    Etiology: 
Investigations: Complete blood count 
Electrolytes: Na+, K+, Cl- 
Calcium, Phosphorus 
RBS: 
ABG: 
Liver function test: 
Renal function test: 
Blood culture: 
Urine Culture: 
CSF analysis: 
CXR: X-ray abdomen: 
Ultrasound abdomen: 
ECG: ECHO: 
Treatment given: 
IV fluids: 
Antibiotics: 
Vasopressors: Dopamine: 
Dobutamine: 
Epinephrine: 
Norepinephrine: 
O2: l/min 
Ventilator: 
Specific Treatment: 
LIST OF ABBREVIATIONS 
 
ALT   →  Alanine Amino Transferase 
AST   →  Aspartate Amino Transferase 
ARDS   → Acute Respiratory Distress Syndrome 
ABG   → Arterial Blood Gas 
BP   → Blood Pressure 
CNS   → Central Nervous System 
CI   → Cardiac Index 
CRT   → Capillary Refilling Time 
CPTG   → Core and Peripheral Temperature Gradient 
CRP   → C-reactive protein 
ED   → Emergency Department 
DBP   → Diastolic Blood Pressure 
FIO2   → Fraction of Inspired Oxygen 
GCS   →  Glasgow Coma Scale 
IL-1   → Interleukin-1 
IL-2   → Interleukin-2 
IL-6   → Interleukin-6 
IL-8   → Interleukin-8 
IL-10   → Interleukin -10 
MAP   → Mean Arterial pressure 
NO   → Nitric Oxide 
PaO2   → Partial Pressure of Arterial Oxygen 
PCO2  → Partial Pressure of Carbon Dioxide 
PICU   → Pediatric Intensive Care Unit 
PtcO2   → Transcutaneous Partial Pressure of Oxygen 
PtcCO2  →  Transcutaneous Partial Pressure of Carbon Dioxide 
PCT   → Procalcitonin 
SBP  →  Systolic Blood Pressure 
SIRS   → Systemic Inflammatory Response Syndrome 
SpO2   → Saturation of Oxygen 
SVR   → Systemic Vascular Resistance 
SVRI   → Systemic Vascular Resistance Index 
SVCO2  →  Superior Venacaval Oxygen Saturation (mixed venous  
oxygen saturation) 
 
TNF ALFA  →  Tumor Necrosis Factor - Alfa 
WHO   → World Health Organization 
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INTRODUCTION 
 
Shock or circulatory failure is an acute syndrome characterized by 
inadequate circulatory perfusion of tissues to meet the metabolic demands 
of vital organs1. 
Shock is one of the commonest pediatric emergencies.2 The shock 
states in children are classified according to the etiological factors namely 
hypovolemic shock due to volume depletion, cardiogenic shock due to 
cardiac dysfunction, distributive shock due to abnormal vasodilatation and 
septic shock due to increased vascular permeability. 
Early recognition with efficient, anticipatory, and aggressive 
management of children in shock is mandatory and will often be 
rewarding, as early restoration of tissue perfusion to normalcy will 
determine the immediate outcome. The final outcome will depend upon 
the nature of etiology2 and the availability of intervention measures. 
These children with shock are often referred to tertiary care facility 
for admission and management. The time lapse between the onset of this 
state and the ·time of admission and initiation of resuscitative measures is 
a great factor in determining the outcome.3 These children are looked after 
in a pediatric intensive care setup where constant observation and vigil 
2 
 
with appropriate monitoring of various clinical parameters and laboratory 
parameters will determine and modify the therapeutic intervention which 
in turn will determine the outcome. 
In any pediatric setup, pediatric shock states are often secondary to 
hypovolemic states, envenomation secondary to scorpion sting, gram-
negative septicemia, cardiac dysfunction, and anaphylactic reaction. This 
study is a prospective observational study of shock states in children 
beyond neonatal period (> 30 days to 12 years). As mentioned earlier, this 
is one of the commonest emergencies in pediatrics wherein the mortality 
rate is found to be quite significant. The mortality rate is extremely high 
in septic shock even in developed countries2, where as the outcome in 
shock states secondary to envenomation is extremely gratifying. Hence 
this study is undertaken so as to find out the occurrence of this problem 
among pediatric admissions, the various causes contributing to them and 
to assess the outcome in relation to the various clinical and monitoring 
parameters. 
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AIM OF THE STUDY 
1. To find out the incidence of shock states in pediatric age group in 
Govt. Rajaji Hospital, Madurai.  
2. To categorize the shock states based on etiology.  
3. To find out association of various clinical and monitoring 
paramerters of shock with outcome.   
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REVIEW OF LITERATURE 
Shock is an acute, complex state of circulatory dysfunction that 
results in failure to deliver sufficient amounts of oxygen and other 
nutrients to meet tissue metabolic demands and, if prolonged, leads to 
multiple organ failure and death.4 Shock states, therefore, may be viewed 
as a state of acute cellular oxygen deficiency. Shock is not a problem of 
blood pressure or blood volume, but, whatever the causative factors, it is 
always a problem of inadequate cellular sustenance.5-7 Shock can be 
caused by any serious disease or injury; it is the final common pathway to 
death.  
Delivery of oxygen is a direct function of the cardiac output and the 
arterial oxygen content. Inadequate oxygen delivery can result from either 
limitation or maldistribution of blood flow8. Occasionally increased 
oxygen requirements (fever, sepsis, or trauma) may result in cellular 
oxygen deficiency with normal blood flow and oxygen delivery. Reduced 
oxygen content (anemia, poor arterial oxygen saturation) requires higher 
cardiac output to maintain oxygen delivery. 
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When oxygen delivery fails to meet cellular oxygen demands, 
various compensatory mechanisms are activated. Shock, therefore, is a 
dynamic process; the exact cardiorespiratory pattern clinically detected 
depends on the complex interaction of patient, illness, time elapsed, and 
treatment provided.4-9 
Because of its progressive nature, shock may be divided into 
phases: compensated, uncompensated, and irreversible.4  
I) Compensated or Early Shock: Implies that vital organ function is 
maintained by intrinsic compensatory mechanisms such as 
venoconstriction, fluid shift from interstitial to intra-vascular space and 
arteriolar vasoconstriction. 
The features are: 
• Normal blood pressure 
• Tachycardia. 
• Narrow pulse pressure (as in hypovolemic shock) or wide pulse 
pressure (In septic shock). 
• Signs of peripheral vasoconstriction evidenced by decreased skin 
temperature and impaired  capillary refill >2secs. 
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• Signs of extracellular fluid loss like sunken eyes and anterior 
fontanelle, dry buccal mucosa and poor skin turgor may be present. 
If shock is identified and vigorously treated at this stage, the 
syndrome may be successfully reversed. 
II) Decompensated Shock: As the shock progresses to this state, the 
efficiency of the cardiovascular system is undermined, and microvascular 
perfusion becomes marginal despite compensatory adjustments. This 
phase has all the features of compensated shock and also has hypotension. 
III) Irreversible or terminal shock: This phase implies damage to key 
organs of such magnitude that death occurs even if therapy returns 
cardiovascular parameters to normal levels. 
By this stage, no matter what the initial classification of, a given 
shock state may have been, there are gross abnormalities in volume status, 
vascular tone, cardiac function, and cellular energetics and multiorgan 
failure. No currently measured parameter is sufficiently sensitive and 
specific to act as gold standard indicator of irreversible shock.2 
Shock states may be classified into six functional categories: 
• Hypovolemic 
• Cardiogenic 
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• Obstructive 
• Distributive 
• Septic 
• Miscellaneous. 
Another functional category of shock, traumatic shock is also being 
used recently. 
It is important to note that such tidy classifications imply a degree 
of precision that will be misleading when approaching an individual 
patient. Vicious cycles play a prominent role in most shock syndromes; 
any given patient, over time, may display features of any functional 
category.5 
ETIOLOGIES OF THE DIFFERENT FUNCTIONAL 
CATEGORIES OF SHOCK 
Hypovolemic shock: The causes of hypovolemic shock are listed below.4 
1)Whole blood loss 
i) Hemorrhage - absolute loss 
a) External Bleeding 
b) Internal Bleeding 
c) Gastrointestinal 
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d) Intra-abdominal (spleen, liver) 
e) Major vessel injury 
f) Intracranial (in infants) 
g) Fractures 
ii) Relative Loss 
a) Pharmacological (barbiturates, vasodilators) 
b) Positive - pressure ventilation 
c) Spinal cord injury 
d) Sepsis 
e) Anaphylaxis 
2)Plasma loss 
i)Burns 
ii) Capillary leak syndromes 
a) Inflammation sepsis 
b) Anaphylaxis 
iii) Protein - losing syndromes 
a) Nephrosis 
b) Intestinal disorders or obstruction 
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3)Fluid and electrolyte loss 
a) Vomiting and diarrhea 
b)Excessive diuretic use 
c)Endocrine 
Cardiogenic shock 
The causes of cardiogenic shock are listed below.11,12 Cardiac 
function can also be depressed in patients with shock that is not primarily 
due to a myocardial insult. 
Myocardial dysfunction is frequently a late manifestation of shock 
of any etiology.13 
1)Heart rate abnormalities 
 Supraventricular tachycardia 
 Ventricular dysarrhythmias 
 Bradycardia 
2)Cardiomyopathies / Carditis 
 Infections 
a) Sepsis 
b) Myocarditis 
 Hypoxic and ischemic events 
10 
 
a) Cardiac arrest 
b) Prolonged shock 
c) Head injury 
d) Anomalous coronary artery 
e) Excessive catecholamine states 
3)Metabolic 
a) Hypoglycemia 
b) Hypocalcaemia 
c) Acidosis 
d) Thyroid disorders 
e) Hypothermia 
f) Glycogen storage disease 
g) Carnitine deficiency 
h) Mucopolysaccharidosis 
4) Vascular, immunological 
a) Kawasaki's disease 
b) Polyarteritis nodosa 
c) Systemic lupus erythematosus 
d) Embolism 
11 
 
e) Acute rheumatic fever 
5) Drug intoxication 
6)Neuromuscular diseases 
a) Duchenne's dystrophy 
b) Friedreich's ataxia 
7)Miscellaneous 
a) Endocardial fibroelastosis 
8 )Congenital heart disease 
9 )Trauma 
Obstructive shock 
Causes of obstructive shock are acute pericardial tamponade, 
tension pneumothorax, pulmonary or systemic hypertension, and 
congenitally acquired outflow obstructions.14 
Distributive shock 
Distributive shock may be seen with anaphylaxis, spinal, or 
epidural anesthesia, disruption of the spinal cord, or inappropriate 
administration of vasodilatory medication.14 
 
 
12 
 
Septic shock 
Septic shock can be caused by bacteria, virus, fungus, or protozoa.15 
Respiratory infections (37%) and primary bacteremia (25%) are the most 
common infections.16 
According to American College of Critical Care Medicine guidelines the 
following are defined as:17 
SIRS (a) (Systemic Inflammatory Response Syndrome) 
The presence of at least two of the following four criteria,  
One of which must be abnormal temperature or leukocyte count:  
* Core temperature of >38.5°C or <36°C. 
* Tachycardia, defined as a mean heart rate >2 SD above normal 
for age in the absence of external stimulus, chronic drugs, or painful 
stimuli; or otherwise unexplained persistent elevation over a 0.5- to 4-hr 
time period OR for children <1 yr old: Bradycardia, defined as a mean 
heart rate <10th percentile for age in the absence of external vagal 
stimulus, beta-blocker drugs, or congenital heart disease; or otherwise 
unexplained persistent depression over a 0.5-hr time period. 
13 
 
* Mean respiratory rate >2 SD above normal for age or mechanical 
ventilation for an acute process not related to underlying neuromuscular 
disease or the receipt of general anesthesia. 
* Leukocyte count elevated or depressed for age (not secondary to 
chemotherapyinduced leucopenia) or >10% immature neutrophils. 
Infection: A suspected or proven (by positive culture, tissue stain, or 
polymerase chain reaction test) infection caused by any pathogen OR a 
clinical syndrome associated with a high probability of infection. 
Evidence of infection includes positive findings on clinical exam, 
imaging, or laboratory tests (e.g., white blood cells in a normally sterile 
body fluid, perforated viscus, and chest radiograph consistent with 
pneumonia, petechial or purpuric rash, or purpura fulminans). 
Sepsis: SIRS in the presence of or as a result of suspected or proven 
infection. 
Severe sepsis: Sepsis plus one of the following: cardiovascular organ 
dysfunction OR acute respiratory distress syndrome OR two or more other 
organ dysfunctions. 
Septic shock: Sepsis and cardiovascular organ dysfunction 
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ORGAN DYSFUNCTION CRITERIA17 
Cardiovascular dysfunction 
• Despite administration of isotonic intravenous fluid bolus > 40 
mL/kg in 1 hr. 
• Decrease in BP (hypotension) <5th percentile for age or systolic 
BP >2 SD below normal for age OR 
• Need for vasoactive drug to maintain BP in normal range 
(dopamine >5 mcg/kg/min or dobutamine, epinephrine, or norepinephrine 
at any dose) OR  
• Two of the following:   
Unexplained metabolic acidosis:  
base deficit >5.0 mEq/L. 
Increased arterial lactate >2 times upper limit of normal. 
Oliguria: urine output <0.5 mL/kg/hr 
Prolonged capillary refill: >3 secs 
Core to peripheral temperature gap >3°C. 
Respiratory 
• PaO2/FiO2 <300 in absence of cyanotic heart / preexisting lung 
diseases OR 
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• PaCO2 >65 torr or 20 mm Hg over baseline PaCO2 OR 
• Proven need or >50% FiO2 to maintain saturation >92% OR 
• Need for non-elective invasive or noninvasive mechanical 
ventilation. 
Neurologic 
• Glasgow Coma Score <11 OR 
• Acute change in mental status with a decrease in Glasgow Coma 
Score >3 points from abnormal baseline 
Hematologic 
• Platelet count: < 80,000/mm3 or a decline of 50% in platelet 
count from highest value recorded over the past 3 days (for chronic 
hematology/oncology patients). 
OR 
• International normalized ratio >2. 
Renal 
• Serum creatinine >2 times upper limit of normal for age or  2-fold 
increase in  baseline creatinine. 
Hepatic 
• Total bilirubin >4 mg/dl (not applicable for newborn) OR 
• ALT 2 times upper limit of normal for age (BP, blood pressure; 
ALT, alanine transaminase. 
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EPIDEMIOLOGY  
Shock occurs in approximately 2% of all hospitalized children and adults 
in the United States (300-400, 000/yr).1 
Hypovolemia is the most common cause of shock in children.4 In 
health institutions in India up to a third of hospital admissions are diarrhea 
related and up to 17% of all deaths in indoor pediatric patients are 
gastroenteritis related.18 The World Health Organization estimates that in 
developing countries 3 million children under the age of 5 years die of 
diarrhea each year, primarily because of hypovolemic shock, secondary to 
the vomiting and diarrhea that occurs with a variety of infectious agents.19 
Pediatric severe sepsis per year in the United States is 0.56 cases 
per 1,000 population per year.16 The incidence is highest in infants (5.16 
per 1,000), fell dramatically in older children (0.20 per 1,000 in 10 to 14 
year olds), and is15% higher in boys than in girls (0.60 versus 0.52 per 
1,000, p<0.001). Hospital mortality was 10.3%, or 4,383 deaths nationally 
(6.2 per 100,000 population).16 Septic shock is the most common cause of 
death in the medical and surgical intensive care units.20 
There are approximately 1500 annual deaths from anaphylaxis in 
the United States.21 
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PATHOPHYSIOLOGY OF CIRCULATORY SHOCK – 
GENERAL OVERVIEW 
Circulatory shock results in critical decreases in tissue perfusion 
that result in organ dysfunction.The initial response of the cardiovascular 
system to critical reduction to tissue perfusion is a complex set of reflexes 
that serve to maintain vascular tone and cardiac performance. 
Increased sympathetic activity increases cardiac contractility and 
heart rate. Release of catecholamines, vasopressin, and angiotensin 
increases venular and arteriolar tone, augmenting central blood volume, 
venous return, and blood pressure. 
Concomitantly, blood flow is preferentially redirected away from 
skeletal muscle, subcutaneous tissue, and splanchnic circulation to the 
brain and heart. Vasopressin and renin-angiotensin system also augment 
salt and water retention, thereby preserving intravascular blood volume. 
As the shock state progresses, these mechanisms become less 
effective. Hypotension impairs coronary perfusion, thereby compromising 
cardiac output. 
Further increases in peripheral vascular resistance adversely affect 
cardiac performance by increasing ventricular afterload. Tissue acidosis 
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and build up of other metabolites produce arteriole vasodilatation, 
worsening ongoing hypotension. When coupled with venular 
vasoconstriction, capillary hydrostatic pressures increase, with subsequent 
loss of intravascular volume.  
In a group of patients, primarily with septic shock and some drug 
intoxications, the shock state is characterized by profound hypotension, 
unresponsive to endogenous and exogenous vasopressors. These patients 
have a marked hyperdynamic circulatory state and maldistribution of 
systemic blood flow resulting in tissue hypoperfusion. The deterioration 
to a hypodynamic state occurs as a terminal event in these patients.  
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PATHOPHYSIOLOGY OF THE FUNCTIONAL 
CATEGORIES OF SHOCK 
1) Hypovolemic Shock 
Hypovolemia is the most common cause of shock in infants and 
children. Hypovolemic shock is best defined as a sudden decrease in the 
intravascular blood volume relative to the vascular capacity to the extent 
that effective tissue perfusion cannot be maintained.23 
Physiological mechanisms of the body compensate for the loss of 
intravascular fluid in children in the same way that they do in adults.4, 7 
Acute losses of 10% to 15% of the circulatory blood volume are well 
tolerated and in healthy children are easily compensated. Activation of 
peripheral and central baroreceptors produce an outpouring of 
catecholamines, and the resulting tachycardia and peripheral 
vasoconstriction are usually adequate to support the blood pressure with 
little or no evidence of hypotension. An acute loss of 25% or more of the 
circulating blood volume, however, frequently results in a clinically 
apparent hypovolemic state that requires immediate, aggressive 
management.24 
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The most reliable indicators of early, compensated hypovolemic 
shock in children are persistent tachycardia, cutaneous vasoconstriction, 
and diminution of the pulse pressure. The best clinical evidence of 
decreased tissue perfusion is skin mottling, prolonged capillary refill, and 
cold extremities. Systemic arterial blood pressure is frequently normal, 
the result of increased systemic vascular resistance.4 Neurological status is 
normal or only minimally impaired. With continued loss of blood volume 
or with delayed or inadequate blood volume replacement, the 
intravascular fluid losses surpass the body's compensatory abilities, and 
decompensated phases appear. The pronounced systemic vasoconstriction 
and hypovolemia produce ischemia and stagnant hypoxia in the visceral 
and cutaneous circulations.22 Altered cellular metabolism and function 
occur in these areas, resulting in damage to blood vessels, kidneys, liver, 
pancreas, and bowel. Stroke volume and cardiac output are decreased4. 
Patients are hypotensive, acidotic, lethargic or comatose, and oliguric or 
anuric. It is important to emphasize that arterial blood pressure falls only 
after compensations are exhausted, which may occur long after the 
precipitating event and after severe reduction in cardiac output.25 Terminal 
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phases of hypovolemic shock are characterized by myocardial dysfunction 
and widespread cell death. 
2) Cardiogenic Shock 
Cardiogenic shock is the pathophysiological state in which an 
abnormality of cardiac function is responsible for the failure of the 
cardiovascular system to meet the metabolic needs of tissues.4,26 The 
common denominator is depressed cardiac output, which in most 
instances is the result of decreased myocardial contractility. Cardiac 
function can also be depressed in patients with shock that is not primarily 
due to a myocardial insult. Myocardial dysfunction is frequently a late 
manifestation of shock of any etiology.  
Although the cause of myocardial dysfunction in such patients, is 
not completely understood, the following mechanisms have been 
proposed: 
(1) Specific toxic substances released during the course of shock 
that have a direct cardiac depressant effect. 
(2) Myocardial edema. 
(3) Adrenergic receptor dysfunction. 
(4) Impaired sarcolemmal calcium flux. 
(5) Reduced coronary blood flow resulting in impaired myocardial 
systolic and diastolic function.13 
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As opposed to hypovolemic shock; compensatory responses can 
have deleterious effects in patients with cardiogenic shock.27,28 
Compensatory responses are nonspecific and not precisely set, and in 
patients with cardiogenic shock they may contribute to the progression of 
shock by further depressing cardiac function. For example, as pump 
function deteriorates and cardiac output decreases, systemic vascular 
resistance increases in order to maintain circulatory stability. However, 
the increase in afterload adds to the heart's workload and further decreases 
pump function.28 Therefore, in cardiogenic shock, a vicious cycle is 
established. Ventricular dysfunction is exacerbated by neurohumoral 
vasoconstrictive mechanisms, and vice versa. Because of the self-
perpetuating cycle, compensated phases of cardiogenic shock may not be 
observed, and frequently only one cardiorespiratory pattern, in varying 
degrees of severity, is observed. The patients are tachycardic, 
hypotensive, diaphoretic, oliguric, and acidotic. Extremities are cool and 
mental status is altered. Hepatomegaly, jugular venous distention, rales, 
and peripheral edema may be observed.4, 27 Cardiac output is depressed, 
and elevations in central venous pressure, pulmonary capillary wedge 
pressure, and systemic vascular resistance are observed. 
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3) Obstructive Shock 
Obstructive shock is caused by the inability to produce adequate 
cardiac output despite normal intravascular volume and myocardial 
function. Causative factors may be within the pulmonary circulation or 
the systemic circulation or associated with the heart itself. Examples of 
obstructive shock include acute pericardial tamponade, tension 
pneumothorax, pulmonary or systemic hypertension, and congenitally  
acquired outflow obstructions. Recognition of the characteristic features 
of these syndromes is essential, as most of the causes are treatable, 
provided the diagnosis is made early.14 
4) Distributive Shock 
Distributive shock results from maldistribution of blood flow to the 
tissue. 
Abnormalities in the distribution of blood flow may result in 
profound inadequacies in tissue oxygenation, even in the face of a normal 
or high cardiac output. Such maldistribution of flow generally results 
from widespread abnormalities in vasomotor tone. Distributive shock may 
be seen with anaphylaxis, spinal, or epidural anesthesia, disruption of the 
spinal cord, or inappropriate administration of vasodilatory medication.14 
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5) SEPTIC SHOCK 
Septic shock is the most complex and controversial type of shock 
and merits independent classification. Septic shock often is the 
combination of multiple problems, including hypovolemia, 
maldistribution of blood flow, myocardial depression, and multiple 
metabolic and endocrinological problems.29,30 
This form of shock is caused by the systemic response to a severe 
infection. Gram-positive and -negative bacteria, viruses, fungi, rickettsiae, 
and protozoa have all been reported to produce the clinical picture of 
septic shock, and the overall response is generally independent of the 
specific type of invading organism. The clinical findings in septic shock 
are a consequence of the combination of metabolic and circulatory 
derangements driven by the systemic infection and the release of toxic 
components of the infectious organisms, e.g., the endotoxin of gram-
negative bacteria or the exotoxins and enterotoxins of gram-positive 
bacteria. Organism toxins lead to the release of cytokines, including IL-
1.IL-6, IL-8, IL-12, INF gamma, G-CSF and TNF-a, from tissue 
macrophages. Tissue factor expression and fibrin deposition are increased, 
and disseminated intravascular coagulation may develop. The inducible 
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form of NO synthase is stimulated, and NO, a powerful vasodilator, is 
released. Hemodynamic changes in septic shock occur in two 
characteristic patterns: early, or hyperdynamic, and late, or hypodynamic, 
septic shock. 
Hyperdynamic Response: In hyperdynamic septic shock, tachycardia is 
present, the cardiac output is normal, and the systemic vascular resistance 
is reduced while the pulmonary vascular resistance is elevated. The 
extremities are usually warm. However, splanchnic vasoconstriction with 
decreased visceral flow is present. The venous capacitance is increased, 
which decreases venous return. With volume expansion cardiac output 
becomes supranormal. Myocardial contractility is depressed in septic 
shock by mediators including NO, IL-1, and/or TNF-a. Inflammatory 
mediator-induced processes include increased capillary permeability and 
continued loss of intravascular volume. 
In septic shock, in contrast to other types of shock, total oxygen 
delivery may be increased while oxygen extraction is reduced due to 
maldistribution of microcirculatory perfusion and impaired utilization. In 
this setting the presence of normal mixed venous oxygen saturation is not 
indicative of adequate peripheral perfusion, and even though the cardiac 
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output may be elevated, it is still inadequate to meet the total metabolic 
needs. 
The toxicity of the infectious agents and their byproducts and the 
subsequent metabolic dysfunction drive the progressive deterioration of 
cellular and organ function. Acute respiratory distress syndrome, 
thrombocytopenia, and neutropenia are common complications. 
Hypodynamic Response: As sepsis progresses, vasoconstriction occurs 
and the cardiac output declines. The patient usually becomes markedly 
tachypneic, febrile, diaphoretic, and obtunded, with cool, mottled, and 
often-cyanotic extremities. Oliguria, renal failure, and hypothermia 
develop; there may be striking increases in serum lactate.15 
6) Traumatic Shock 
Shock following trauma is, in large measure, due to hypovolemia. 
However, even when hemorrhage has been controlled, patients can 
continue to suffer loss of plasma volume into the interstitium of injured 
tissues. These fluid losses are compounded by injury-induced 
inflammatory responses, which contribute to the secondary 
microcirculatory injury. This causes secondary tissue injury and 
maldistribution of blood flow, intensifying tissue ischemia and leading to 
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multiple organ system failure. Trauma to the heart, chest, or head can also 
contribute to the shock. For example, pericardial tamponade or tension 
pneumothorax impairs ventricular filling, while myocardial contusion 
depresses myocardial contractility.15 
The detection of altered organ function in the acutely ill patient 
constitutes multiple organ dysfunction syndromes (two or more organ 
involvement). The terminology dysfunction identifies this process as a 
phenomenon in which organ function is not capable of maintaining 
homeostasis. This process, which may be absolute or relative, can be more 
readily identified as a continuum of change over time. 
COMPLICATIONS OF SHOCK 
Respiratory failure is a frequent complication in shock and may be 
due to failure of the ventilator pump, i.e., respiratory muscle fatigue or 
deterioration of lung function, i.e., respiratory distress syndrome.4,31 For 
these reasons, increased inspired oxygen is essential in all children with 
shock. In order to ensure the airway, provide relief from respiratory 
muscle fatigue, and facilitate provision of positive airway pressure, early 
tracheal intubation should be considered.4, 10 
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Progressive azotemia, with or without oliguria, may develop in 
association with any of the shock syndromes. The shock-related renal 
failure syndromes are a continuum from acute prerenal failure, through 
classic acute tubular necrosis, to the extreme of cortical necrosis. 
Although the precise mechanisms involved in the production of renal 
failure are unclear, diminished renal perfusion because of persistent 
vasospasm with reduced glomerular filtration rate, enhanced distal 
exchange site activity secondary to increased aldosterone production, and 
increased free water absorption under the influence of elevated 
antidiuretic hormone activity all seem to be operative10. High output renal 
failure may occur in shock states, without any previous episodes of 
oliguria. This may falsely suggest adequate renal perfusion and adequate 
prerenal augmentation at a time when the patient's intravascular volume 
is, in fact, being depleted.4, 32 
Coagulation abnormalities (e.g., disseminated intravascular 
coagulation) probably occur to some extent in all forms of shock. 
Monitoring of prothrombin time, partial thromboplastin time, and platelet 
count and observation for excessive bleeding are essential.32 
Hepatic dysfunction occurs in varying degrees in most shock states. 
29 
 
Gastrointestinal disturbances after hypoperfusion and stress include 
bleeding and ileus. Ileus may result from electrolyte abnormalities and 
may lead to abdominal distention with respiratory compromise. 
Multiple endocrinological problems may arise and complicate the 
management of children in shock. Included in these are problems with 
fluid, electrolytes, and mineral balance. Severe abnormalities of calcium 
homeostasis can occur in the course of any acute hemodynamic 
deterioration. Marked decreases in serum ionized calcium levels have 
been reported in conditions associated with inadequate tissue perfusion, 
regardless of etiology.14 
 
DIAGNOSIS OF SHOCK 
Shock is a clinical diagnosis.2 The history and the clinical 
evaluations will facilitate early etiologic classification of shock, and help 
in directing appropriate treatment.33 This is the simplest and most rapid 
means for detecting the state of inadequate perfusion, determining which 
tissues are compromised, and gauging the efficacy of therapy.2 
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HISTORICAL INFORMATION AND CLINICAL SIGNS IN 
DIFFERENT SHOCK FORMS 
 HYPOVOLEMIC 
SHOCK 
CARDIOGENIC 
SHOCK 
DISTRIBUTIVE 
SHOCK 
History Trauma, vomiting, 
diarrhea 
Congenital heart 
disease, past 
cardiac surgery, 
refusal of feeds 
and respiratory 
distress 
Fever, lethargy, 
poor feeding, 
irritability and 
abnormal skin 
colour. 
Heart 
rate 
Increased Increased Increased 
Chest x-
ray 
   
Heart 
size 
Small Large Small 
Lungs Clear Wet Clear (in the early
stage) 
Gallop 
rhythm 
Not present Present Not present 
Capillary 
refill 
time 
Prolonged Prolonged Normal (in the 
early stage) 
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STAGES OF SEPTIC SHOCK33 
Early stage (hyperdynamic)                    Late stage (cardiogenic) 
1. Hyperthermia                                          1. Hypothermia 
2. Tachycardia                                             2. Tachycardia 
3. Tachypnea                                               3. Bradypnea                                                     
4. Warm extremities                                     4.Cold mottled extremities                           
5. Bounding pulse                                        5. Weak, thready pulse                                      
6. Normal capillary refill                              6. Prolonged capillary refill 
         
7. Normotensive/hypertensive                      7. Hypotensive 
8. Hypoxia                                                8. Hypoxia 
9. Polyuria      9. Oliguria/anuria 
10. Increased cardiac output                        10. Decreased cardiac output 
11. Decreased SVR    11. Increased SVR 
12. Normal CNS     12. Obtunded, comatose 
13. Respiratory alkalosis    13. Metabolic acidosis 
14. Hyperglycemia    14. Hypoglycemia 
15. Normal coagulation    15. Disseminated  
       intravascular coagulopathy 
CNS → Central Nervous System, SVR → Systemic Vascular Resistance 
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Further assessment of the severity and cause of shock states is 
greatly assisted by laboratory investigations. Routine laboratory tests such 
as serum electrolytes, serum calcium blood cell counts, platelet counts, 
and hematocrit are obviously necessary to delineate the extent of 
metabolic disturbance. Probably the most valuable investigation is the 
arterial blood gas analysis. 
Arterial oxygen content and carbon dioxide tension aid in the 
adequacy of ventilatory function that is frequently impaired in shock. In 
addition pH and base deficit determination serves as one of the most 
readily available methods of quantifying tissue hypoperfusion.2 
Management of shock17 
In 2003, critical care and infectious disease experts representing 11 
international organizations developed management guidelines for other 
supportive therapies in sepsis that would be of practical use for the 
bedside clinician, under the auspices of the Surviving Sepsis Campaign, 
an international effort to increase awareness and to improve outcome in 
severe sepsis. Practical application of this information in Indian set up in a 
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child with septic shock will be discussed. In 1992, ACCP/SCCM 
consensus guidelines for definitions of sepsis were published by              
Bone et al. 
MONITORING OF SHOCK 
The most effective and sensitive physiologic monitoring available 
is the frequent, repeated examination of the child by a competent, careful 
observer. Observations for alterations in peripheral perfusion by 
examining capillary refill time and core –peripheral temperature gradient, 
color, presence of cyanosis, characteristics of the pulse, blood pressure, 
respiratory pattern, and level of consciousness are absolutely essential in 
the continuous and ongoing monitoring of children with shock. Careful 
nursing observation of vital signs and activity of the child and clear, 
concise display of these data from the central core of information from 
which the child's therapy is determined.2 
Minimal monitoring of the child in shock or at risk for shock 
should include continuous electrocardiographic monitoring, frequent 
blood pressure and temperature measurements, and measurement of blood 
glucose in younger infants.34 
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Other variables that have been used to monitor patients, guide 
therapy, and predict outcome include mean arterial pressure, central 
venous pressure, Swan-Ganz catheter placement, mixed venous oxygen 
saturation, oxygen delivery and consumption, gastric mucosal pH, blood 
lactate level, and echocardiography.35 
Early goal directed therapy helps keep the cost and duration of 
hospital stay to a minimum. 
Need for early intubation and ventilation 
Due to low functional residual capacity, young infants and neonates 
with severe sepsis may require early intubation. Unfortunately no 
objective clinical criteria specific to pediatric septic shock for timing of 
endotracheal intubation (other than the standard indications, which 
include shock) exist in literature. Therefore it is reasonable to consider 
endotracheal intubation when shock is persistent even after a volume 
resuscitation of  >40-60 ml/kg. Children with sepsis requiring aggressive 
fluid resuscitation frequently have worsening tachypnea and increasing 
oxygen requirement clinically depicting early acute respiratory distress 
syndrome (ARDS).These patients will require early intubation and 
mechanical ventilation. The principles of lung- protective strategies (low 
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tidal volumes and permissive hypercapnea) are applied to children as they 
are to adults. In premature infants, additional attention is paid to avoiding 
hyperoxemia to prevent retinopathy. 
Fluid Resuscitation 
Intravenous access for fluid resuscitation and inotrope/vasopressor 
infusion is more difficult to attain in children than in adults. The 
American Heart Association has well established Pediatric advanced life 
support (PALS) guidelines for emergency establishment of intravascular 
support including intraosseous access. On the basis of many studies, it is 
accepted that aggressive fluid resuscitation with crystalloids or colloids is 
of fundamental importance to survival of septic shock in children. 
There is only one randomized, controlled trial comparing the use of 
colloid with crystalloid resuscitation (dextran, gelatin, lactated Ringers, or 
saline) in children with dengue shock. All these children survived, 
regardless of the fluid used, but the longest time to recovery from shock 
occurred in children who received lactated Ringers. Among patients with 
the narrowest pulse pressure, there was a suggestion that colloids were 
more effective than crystalloids in restoring normal pulse pressure. Fluid 
infusion is best initiated with boluses of 20mL/kg over 5-10 mins, titrated 
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to clinical monitors of cardiac output, including heart rate, urine output, 
capillary refill, and level of consciousness. 
A 60 ml syringe filled with fluid drawn via the fluid bag with a 
three-way connection can be conveniently used to push fluid boluses in 
the absence of a volumetric pump. Children normally have a lower blood 
pressure than adults and can prevent reduction in blood pressure by 
vasoconstriction and increasing heart rate. Therefore, blood pressure by 
itself is not a reliable endpoint for assessing the adequacy of resuscitation. 
However, once hypotension occurs, cardiovascular collapse may 
soon follow. 
Hepatomegaly occurs in children who are fluid overloaded and can 
be a helpful sign of the adequacy of fluid resuscitation. Other practical 
ways to assess fluid overload are jugular venous distension, heart size and 
pulmonary congestion on chest x ray. Gold standard still remains the 
measurement of a central venous pressure. Large fluid deficits typically 
exist, and initial volume resuscitation usually requires 40-60 ml/kg but 
can be much higher. 
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Vasopressors / Inotropes 
Should only be used after appropriate volume resuscitation. 
Children with severe sepsis present with low cardiac output and high 
systemic vascular resistance (cold shock, more common scenario), high 
cardiac output and low systemic vascular resistance, or low cardiac output 
and low systemic vascular resistance shock. 
Early inotropic support should be started in the case of fluid 
refractory shock or a life threatening hypotension when fluid bolus has 
been initiated. Dopamine is the first choice of support for the pediatric 
patient with hypotension refractory to fluid resuscitation. The choice of 
vasoactive agent is determined by the clinical examination. Dopamine-
refractory shock may reverse with epinephrine (adrenaline) or 
norepinephrine (noradrenaline) infusion. 
Pediatric patients with low cardiac output states may benefit from 
use of dobutamine. The use of vasodilators can reverse shock in pediatric 
patients who remain hemodynamically unstable with a high systemic 
vascular resistance state despite fluid resuscitation and implementation of 
inotropic support. Nitrosovasodilators with a very short half-life 
(nitroprusside or nitroglycerin) are used as first-line therapy for children 
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with epinephrine-resistant low cardiac output and elevated systemic 
vascular-resistance shock. 
Inhaled nitric oxide reduced extracorporeal membrane oxygenation 
use when given to term neonates with persistent pulmonary artery 
hypertension of the newborn and sepsis in a randomized, controlled trial. 
When pediatric patients remain in a normotensive low cardiac output and 
high vascular resistance state, despite epinephrine and nitrosovasodilator 
therapy, then the use of a phosphodiesterase inhibitor should be strongly 
considered, such as milrinone. Vasopressin therapy should be considered 
in warm shock unresponsive to fluid and norepinephrine. 
Early antibiotics 
After appropriate cultures are taken early use of broad spectrum 
systemic antimicrobial therapy based on clinical suspicion is reasonable 
although no randomized studies exist in children. Adult data supports use 
early appropriate antibiotics to impact favorably on morbidity from septic 
shock. 
Therapeutic end points 
Therapeutic endpoints are capillary refill of <2 secs, normal pulses 
with no differential between peripheral and central pulses, warm limbs, 
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urine output of >1 ml/kg/hr, normal mental status, decreased lactate, and 
increased base deficit and superior venacava or mixed venous oxygen 
saturation of >70%. When employing measurements to assist in 
identifying acceptable cardiac output in children with systemic arterial 
hypoxemia such as cyanotic congenital heart disease or severe pulmonary 
disease, arterial-venous oxygen content difference is a better marker than 
mixed venous hemoglobin saturation with oxygen. Optimizing preload 
optimizes cardiac index. 
As noted above, blood pressure by itself is not a reliable endpoint 
for resuscitation. Rarely, if a pulmonary artery catheter is utilized, 
therapeutic endpoints are cardiac index of >3.3 and <6.0 L/m/meter sq 
with normal perfusion pressure (mean arterial pressure-central venous 
pressure) for age. Use of pulmonary artery catheter has declined over the 
years due to no well-demonstrated therapeutic benefit in patients with 
septic shock. 
Electrolyte balance 
An attempt should be made to check and correct common 
electrolyte problems related to sodium (hyponatremia), potassium and 
ionized calcium (ionized hypocalcemia). 
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Steroids 
Hydrocortisone therapy should be reserved for use in children with 
catecholamine resistance and suspected or proven adrenal insufficiency. 
Patients at risk include children with severe septic shock and purpura, 
children who have previously received steroid therapies for chronic 
illness, and children with pituitary or adrenal abnormalities. 
Dose recommendations vary from 1-2 mg/kg for stress coverage 
(based on clinical diagnosis of adrenal insufficiency) to 50 mg/kg for 
empirical therapy of shock followed by the same dose as a 24-hr infusion. 
Thus dose of steroids remains controversial. 
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PROGNOSTIC FACTORS IN SHOCK 
Overall mortality of shock is 20-50%.1 The mortality depends on 
the underlying etiology. Septic shock is associated with high mortality 
whereas hypovolemic shock is associated with least mortality. Mortality 
rates in septic shock in adults ranges from 40-60%.36 In children it varies 
from 10 to 82%.16,37-39 In septic shock, outcome in children is markedly 
better than in adults (9% in children compared with 28% mortality in 
adults).40 
In a retrospective study of the risk factors determining outcome of 
nontraumatic patients with shock in the pediatric emergency service of a 
University Hospital Chang P et al have identified 22 patients with the 
diagnosis of shock which included 11 with septic shock (50%), 7 with 
hypovolemic shock (32%) and 4 with cardiogenic shock (18%). Their age 
ranged from 2 months to 19 years old. Gram-negative bacterial sepsis 
(6/11, 55%), dilated cardiomyopathy (2/4, 50%) and acute gastroenteritis 
(7/7, 100%) were the most frequent causes of septic, cardiogenic and 
hypovolemic shock, respectively. In total, 12 patients (55%) died. The 
mortality rate was high in septic shock (9/11, 82%) and cardiogenic shock 
patients (3/4, 75%), but low in hypovolemic shock patients (0/7, 0%). The 
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risk factors of poor outcome in patients with shock included 
thrombocytopenia, prolonged prothrombin time and partial 
thromboplastin time. Patients with leukopenia, a higher level of C-
reactive protein, or under 2 years of age tended to have poor outcome.39 
Multiple organ systems failure increases the probability of death 
(one organ system involved=25%; two organ systems=60% three or more 
organ systems=>85%).1 When the central nervous system is injured, this 
often becomes the limiting factor that prevents survival. Also ultimate 
outcome in severe shock states is often affected by hepatic dysfunction.14 
Banks and colleagues found that clinical jaundice was apparent in 63 
percent of their patients with septic shock, that it was more common in 
non-survivors than survivors, and that the degree of biochemical liver 
abnormalities was related to the duration of shock.41 
The French ICU Group for Severe Sepsis have concluded that the 
major determinants of both early (< 3 days) and secondary deaths in 
adults with severe sepsis were the Simplified Acute Physiology Score II 
(SAPS II) and the number of acute organ system failures. Other risk 
factors for early death included a low arterial blood pH (<7.33) and shock, 
whereas secondary deaths were associated with the admission category, a 
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rapidly or ultimately fatal underlying disease, a preexisting liver or 
cardiovascular insufficiency, hypothermia, thrombocytopenia, and 
multiple sources of infection. In patients with documented sepsis, 
bacteremia was associated with early mortality.42 
In case of septic shock neutropenia, hypothermia, and 
encephalopathy are associated with poor outcome. Most patients who do 
not recover initially die later. The correct choice of antibiotic has 
consistently been associated with improved outcomes from septic shock.19 
Pollock and associates, in their study in pediatric patients with 
septic shock have shown that the outcome is improved in patients with 
increased cardiac output, elevated oxygen consumption and elevated 
oxygen extraction without significant pulmonary disease. On the other 
hand, low body temperature (< 37 degrees. centigrade), pulmonary 
disease, low cardiac index (< 3.3 I/min/m2) and decreased oxygen 
utilization are all poor prognostic indicators in shock.43 
They suggested that the following changes are associated with poor 
prognosis 
(a) cardiac index values that either do not increase appreciably in 
the middle and latter periods or which increase more than 100% above 
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control values; (b) mean arterial pressures below 50 mm hg in the early 
period; (c) sustained increase in the pulmonary vascular resistance of 
more than 500 dyne.sec/cm5/sq m in the early and middle period; (d) 
arterial PCO2 more than 50 mmHg; (e) pH below 7.3 or above 7.6; (f) 
oxygen consumption below 120 ml/min/sqm in the early period and above 
250 ml/min/sq min in the late period. 
Additional well known information from the literature and common 
clinical experience suggest that the following, if prolonged, may also 
indicate a poor prognosis: (a) urine outputs below 20 ml/hr; (b) CVPs of 
more than 20 cm H2O; (c) heart rates over 150 and under 70 beats per 
minute; (d) arrhythmias; (e) hematocrit vales below 25%; (f) markedly 
increased work of respiration;(g) decreased ventilatory compliance;(h) 
increased pulmonary venous admixture (shunting); (i) increased 
ventilatory dead space; and (j) increased plasma lactate levels and “excess 
lactate”.45 
Heart rate is an early predictor of prognosis in septic shock. Parker 
MM et al have done a study on forty-eight adult patients with septic 
shock, of whom 19 (40%) were survivors and 29 non survivors. At the 
initial evaluation, both survivors and non survivors demonstrated an 
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elevated cardiac index (CI), low systemic vascular resistance index 
(SVRI), and normal stroke volume index. However, only an initial heart 
rate (HR) less than 106 beat/min significantly predicted survival. Twenty-
four hours after the onset of shock, an HR less than 95 beats/min and an 
SVRI greater than 1529 dyne.sec/cm5.m2 predicted survival. Comparing 
the hemodynamic profiles from the initial to the 24 h time point, a 
decrease in HR greater than 18 beats/min or a decrease in CI greater than 
0.5 L/min.m2 predicted survival.52 
To identify early prognostic markers of septic shock among 
catheterization derived hemodynamic and metabolic data a prospective 
cohort study was done at a medical intensive care unit in a university 
hospital. Thirty-two consecutive adult patients with septic shock, 
separated into two groups according to short-term (10-day) evolution: 
18 acute survivors and 14 fatalities. Usual hemodynamic and metabolic 
variables were measured at the onset of shock, i.e., when the catheter was 
inserted (TO), and 24 h later (T24). The values collected for each group at 
TO and T24 and their 24-h changes were compared. On admission, no 
difference was found between acute survivors and eventual fatalities. 
After 24 h, fatalities presented with significantly lower mean arterial 
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pressure, left ventricular stroke work index and higher lactate levels than 
acute survivors. 
Moreover, the 24-h changes of lactate and blood pressure were also 
of prognostic value. 
Oxygen delivery and oxygen consumption did not differ 
statistically between the two groups. At T24, a mean arterial pressure of 
less than 85 mmHg and a lactate level equal to or greater than 3.5mmo/l1 
were independently associated with poor survival (37.5% and 30.7%, 
respectively). Day 10 survival was only 12.5% when both criteria were 
present at T24 Changes in mean arterial pressure and arterial blood lactate 
within the first 24 h of treatment are strong prognostic indicators of short-
term survival in patients with septic shock. After 24 hour of treatment, 
maintenance of a mean blood pressure equal to or greater than 85 mmHg 
correlates with survival at day 10. This data suggest that early reductions 
in both cardiac function and vascular tone play a determining role in the 
hypotension observed in fatalities. Persistence of hyperlactatemia in 
hypotensive patients is associated with poor survival. Blood pressure and 
lactate level are simple bedside parameters that can enable the clinician to 
identify patients with a high risk of mortality.54 
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Hyperlactatemia is an important prognostic marker in shock states. 
In a study by Hatherill M et al. hyperlactatemia was predictive of a poor 
outcome. There was no association between the magnitude of metabolic 
acidosis, quantified by the base excess, and mortality in children with 
shock.55 Suistomaa M et al, observed that hyperlactatemia persisting more 
than 6 hour and simultaneous elevation of lactate/pyruvate ratio are 
associated with increased mortality in critically ill patients.56 In the study 
done by Duke TO et al, blood lactate level was the earliest predictor of 
outcome in children with sepsis. The mean arterial pressure distinguished 
survivors from non-survivors at 24 and 48 hours. The base deficit and 
heart rate did not identify non-survivors from survivors at any time in the 
first 48 h. They also concluded that in children with sepsis, gastric 
tonometry added little to the clinical information that could be derived 
more simply by other means.57 After surgery for complex congenital heart 
disease in children initial lactate concentrations were a poor predictor of 
mortality .However, elevated serum lactate levels indicated postoperative 
complications. In the same study use of base deficit was of no value in 
predicting mortality.58 
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Core-peripheral temperature gradient can also be used to predict 
outcome, although it does not relate to cardiac output or systemic vascular 
resistance.59 Failure to increase toe temperature after heart surgery has 
been associated with an increased risk for death in children after heart 
surgery.60 With the onset of shock, toe temperature can approach an 
ambient level (22-25°C); in one study, patients recovering from shock 
showed widening of toe: ambient gradient of more than 4°C, whereas in 
those who died, the toe: ambient gradient remained 1 to 2c.61 
In pediatric septic shock, the admission PCT, like TNF and IL-10, 
is related to the severity of organ failure and mortality and a fall in PCT 
after 24 hrs of treatment may have favorable prognostic significance.62 
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METHODOLOGY 
This was a prospective observational study of  81 consecutive 
children’s admitted with shock in the pediatric ward  of Government 
Rajaji Hospital, Institute of Child Health & Research Centre ,Madurai , 
over a period of 12 months from October 2009 to September 2010. 
INCLUSION CRITERIA 
• Children more than 1 month and upto 12 years with a clinical 
diagnosis of shock. 
EXCLUSION CRITERIA 
• Neonates 
• Children with traumatic shock (hypovolemic shock due to trauma)    
• Children who die within one hour after admission and patients in 
terminal state of cardiorespiratory failure. 
81 consecutive cases admitted with a clinical diagnosis of shock 
fulfilling the below criteria were taken and their clinical and 
investigational parameters were studied and compared between survivors 
and non-survivors. 
Consent was obtained from the parents/caregivers. Ethical 
committee clearance was taken. 
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WORKING CRITERIA: 
Shock was defined as a clinical state in which the recorded blood 
pressure was <2 standard deviations below the mean for age and/or a state 
in which at least three of the following criteria for decreased perfusion 
were identified: 
1) Decreased peripheral pulses 
2) Mottled or cool extremities 
3) Tachycardia (heart rate> 180 beats per minute for infants and> 
160 beats per minute for children); or  
4) Urine output <1 ml/kg/h, if <30 kg and <0.5 ml/kg if >30 kg. 
5) Capillary refill time.  
 Hypovolemic shock was diagnosed when there was history of fluid 
loss like vomiting, diarrhea, loss of blood etc and physical findings of 
dehydration and shock.  
Cardiogenic shock was identified when there was preexisting heart 
disease or when there were known risk factors to cause myocardial 
damage like scorpion sting and the findings also pointing towards a 
primary cardiac involvement and concomitantly having features of shock 
mentioned above.  
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Septic shock was diagnosed when there was a focus of infection 
like meningitis, encephalitis, or pneumonia proven by clinical features 
and appropriate investigations and also having features of hemodynamic 
compromise. 
Anaphylactic shock was said to be there when there was sudden 
cardiovascular collapse following exposure to an inciting agent. 
Dengue shock was identified when child has fever (2-7 days) and 
hemorrhagic features evidence by one /more of following: 
1. Petechiae / purpura / ecchymosis  
2. Positive tourniquet test  
3. Bleeding from GIT (Hematemesis / Melena) 
4.  Thrombocytopenia ≤ 1 lakh cells / cu.mm 
5. Plasma leakage (Ascites, pleural effusion, > 20% rise in hematocrit) 
plus signs of circulatory failure.    
Once the patient was presented to the emergency room the relevant 
history was taken quickly while instituting appropriate treatment. 
The patients were monitored for the following parameters: 
1. Heart rate 
2. Blood pressure 
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3. Respiratory rate 
4. Capillary Refill Time (CRT) 
5. Core-peripheral temperature gradient (C-PTG) 
6. Glasgow Coma Scale (GCS) 
7. Oxygen saturation (SpO2) and 
8. Urine output 
9. Peripheral pulses  
 
These parameters were recorded periodically from the time of 
presentation and during the hospital stay. The readings at 0, 12, 24 and 48 
hours after admission were analyzed and investigations done at admission 
were also analyzed. Consciousness was assessed using modified GCS for 
infants and children. Heart rate was obtained from the multichannel 
monitoring. Also the pulse was felt and its character assessed, as well as 
blood pressure recording was obtained non-invasively. Respiratory rate 
was counted and recorded. 
Capillary refill time was recorded in the following manner: the 
upper limb was raised slightly above the level of the heart and firm 
pressure was applied by the clinician's index finger and thumb to the 
distal phalanx of the patient's index finger for five seconds. 
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The finger was then released and the time taken for the palmar pulp 
to return to its previous color was recorded. Times were measured to the 
nearest second by a wristwatch. 
Core temperature was measured rectally, and peripheral 
temperature taken on the distal aspect that was not overtly ischemic. SpO2 
was measured by pulse oximetry. 
All the patients were catheterized and the urine output was 
measured.  
Therapy was given based on existing protocols in the institute. For 
hypovolemic shock fluid boluses were given to restore the blood pressure 
and then subsequently dehydration assessed  and corrected. In children 
with cardiogenic shock Dobutamine and vasodilator, were used. 
Septic shock cases were treated with initial 3 boluses of crystalloids 
and then dopamine started if they had persistent shock. If there was no 
response to maximum dose of dopamine (15 μg/kg /min), adrenaline 
infusion was started. In anaphylactic shock cases, adrenaline infusion 
started along with volume expansion. 
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Dengue shock cases were treated with  
5% DNS boluses  - 20ml /kg/hr followed by 10ml /kg/hr infusion.  
If patient improves - IV fluids gradually reduced to 6ml/kg/hr and 
then to 3ml/kg/hr upto 48 hrs.    
If patient doesn’t improve - Fresh whole blood transfusion given at 
10ml/kg/hr and fluid therapy continued at 10ml/kg/hr waiting for 
response. Platelet transfusion were given when platelets <10,000 /cu.mm. 
The outcome measure was ultimate survival or death. 
Statistical analysis were done using SPSS software in the computer. 
 
                                       
 
 
 
 
 
 
 
55 
 
OBSERVATIONS AND RESULTS 
Study design: A prospective clinical study of 81 patients with 
shock was undertaken. 
Table 1: Age distribution of patients studied 
AGE NUMBER PERCENTAGE 
1 month – 1 year 28 34.56 % 
1 year – 5 years 27 33.33 % 
6years- 10 years 21 25.92 % 
>10 years 5 6.1 % 
TOTAL 81 100 % 
 
Figure -1 
 
 
Most common age group is between 1 months- 5 years which 
constitutes 67.89%. 
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Table 2: Sex distribution 
 
SEX NUMBER PERCENTAGE 
Male 40 49.38 % 
Female 41 50.61 % 
Total  81 100 % 
 
Figure 2  
SEX  DISTRIBUTION
MALES
FEMALES
49.38 %50.61 %
 
 Out of  81 cases, 49.38% were males and  50.61%  were females. 
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Table 3: Outcome of the study 
 
OUTCOME NUMBER PERCENTAGE 
SURVIVORS 47 58.02 % 
NON-SURVIVORS 34 41.97 % 
TOTAL 81 100 % 
 
Figure 3 
 
58.02%
41.97%
OUTCOME OF THE STUDY
SURVIVORS
NON SURVIVORS
 
Out of  81 cases ,58.02% survived and 41.97%  were non –survivors. 
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Table 4: Distribution of outcome according to age 
 
AGE 
SURVIVORS  
( n = 47 ) 
NON- SURVIVORS 
( n =34 ) 
NO % NO % 
Upto  1 year 11 23.4 % 17 50 % 
1 year -5 years 14 29.78 % 13 38.23 % 
6 years-10 years 19 40.42 % 2 5.8 % 
>10 years 3 6.38 % 2 5.8 % 
 
Figure 4 
 Distribution of outcome according to age 
 
Mortality rate is higher (50%) among infants < 1 year, while 
survival rate is higher among children among 6 – 10 years age group.           
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Table 5: Distribution of outcome according to sex 
SEX SURVIVORS  
( n = 47 ) 
NON-
SURVIVORS  
( n=34) 
NO % NO % 
MALE 24 51.06 % 16 47.05 % 
FEMALE 23 48.93 % 18 52.94 % 
 
Figure 5  
Distribution of outcome according to sex 
  
Out of 34 non survivors, 47.05 % were  males and 52.94 % were 
females. 
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   Table 6a: Etiology  distribution 
ETIOLOGY NUMBER PERCENTAGE 
Hypovolemic shock 34 41.97 % 
Septic shock 22 27.16 % 
Cardiogenic shock 8 9.8 % 
Dengue shock 17 20.98 % 
Total cases 81 100 % 
 
Figure 6 
Etiology Distribution
HYPOVOLEMIC SHOCK
SEPTIC SHOCK
DENGUE
CARDIOGENIC SHOCK
27.16 %
20.98%
9.80 %
41.97%
 
Out of 81 cases, Hypovlemic shock is most common 41.97% and 
cardiogenic shock is least common ( 9.80%). 
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Table 7: Distribution of outcome according to etiology 
 
ETIOLOGY 
SURVIVORS 
( n = 47 ) 
NON SURVIVORS 
( n =34 ) 
NO % NO % 
Hypovolemic shock 27 57.44 % 7 20.58 % 
Septic shock 7 14.89 % 15 44.11 % 
Cardiogenic shock 2 4.2 % 6 17.64 % 
Dengue shock 11 23.40 % 6 17.64 % 
 
Figure 7 
 Distribution of outcome according to etiology 
  
Out of 34 non survivors, Mortality rate is higher among septic 
shock (44.11 %)  followed by hypovolemic and cardiogenic shock. 
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Table  8  Abnormal Renal function tests  -Distribution 
Etiology Abnormal RFT 
Number Percentage 
Hypovolemic shock 7 30.43% 
Septic shock 9 39.13 % 
Cardiogenic shock 3 13.04% 
Dengue shock 4 17.39% 
Total cases 23 100 % 
 
Table 9 :  Distribution  Of  Severity  of  Shock 
Etiology 
Compensated 
shock 
Decompensate 
shock 
Total 
cases 
Hypovolemic shock 21 (56.75% ) 13( 29.54 %) 34 
Septic shock 5 (13.51 %) 17(38.63 %) 22 
Cardiogenic shock 1(2.7% ) 7( 15.90%) 8 
Dengue shock 10(27.02% ) 7 (15.90%) 17 
Total cases 37(100 %) 44 (100%) 81 
 
Out of 81 cases,37 cases (45.67%) presented in compensated stage, 
while 44 cases(54.32%) presented in decompensated state. out of the 
decompensated shock, septic shock constitutes the majority 
(38.63%).Abnormal RFT noted in 28.39% cases excluding cases where 
RFT not sent. 
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Table  10 : Outcome distribution according to severity  
 
 COMPENSATED 
SHOCK 
DECOMPENSATED 
SHOCK 
SURVIVORS 37 (100 %) 10(22.72%) 
NON SURVIVORS 0 34(77.27%) 
TOTALCASES 37 44 
 
 
Table  11: Comparison of mechanical ventilation among  
survivors and non survivors 
 
 
VENTILATIONS 
SURVIVORS NON SURVIVORS 
NUMBER % NUMBER % 
YES 3 6.3 % 29 85.29% 
NO 44 93.61 % 5 14.70% 
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Table  12: Etiology Distribution 
 
ETIOLOGY TOTAL CASES 
HYPOVOLEMIC SHOCK 34 
 Acute gastroenteritis 32 
Diabetic ketoacidosis 1 
Kerosene poisoning 1 
SEPTIC SHOCK 22 
Septicemia 16 
Meningitis 4 
Empyema 1 
Gluteal abscess 1 
CARDIOGENIC SHOCK 8 
Myocarditis 4 
Dilated cardiomyopathy 1 
Rheumatic heart disease 1 
Scorpion sting 1 
Chronic renal failure 1 
DENGUE SHOCK 17 
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Figure - 8 
Comparision Of Severity Of Shock 
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Figure – 9 
Outcome according to Severity  
 
66 
 
DISCUSSION 
Shock is one of the most common emergencies in pediatrics. In our 
study it is accounted for 81 /7095 admissions in Pediatric ward. In a study 
done by Daljit Singh et al it accounted for 4.5% of PICU admissions.63 
In our study most common age group was less than one year 
(accounting for 34.56%) followed by 1-5years (33.33%). 
In our study male patients constituted about 49.38% and female 
patients 50.61%. This is not in accordance to study by Praveen Khilani et 
al in which males constituted 60%, which  was mainly due to male 
dominated society in India.64 
In this study the overall mortality in shock was 41.97% (34/81) 
which is in concordance with that found in the literature (30-60%).1,39 In a 
study done by Daljith Singh et al mortality was 26.4%.63 
There was no significant influence of  sex on the out come in 
present  study. Similar findings have been observed in Daljit Singh et al 
study.63 But ,children less than 1 year showed higher  mortality rate  and 
children 6-10 years showed higher survival rate. De Freitas and Aragao et 
al found out that in children admitted to ICU mortality was higher in 
children less than 2 years of age.65 And in a study by Chang P et al on 
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non-traumatic shock cases, age less than 2 years tend to have poor 
outcome.39 In a study done by Kumar et al, on triage scoring of severity of 
illness in SIRS children, the mortality increased with decreasing age.66 
In this study, Hypovolemic shock is the most common cause of 
shock 34/81(41.97%) followed by septic shock  22/81(27.16%), Dengue 
shock 17/81(20.98%) and  cardiogenic shock 8/81(9.8%).  
Hypovolemic shock  is the most common cause of shock in 
children as noted in various other studies ,is also noted in our study.2-4,10 
Similarly in other study by Chang P et al, it accounted for 7/22(32%) of 
the cases admitted with shock.39 
The mortality in shock depends on the etiology.2 In this study septic 
shock had maximum mortality 44.11 % (15/34) whereas in other studies it 
ranged from 10-82% in the children,16,33-39 and 40-60% in adults.20,38 In a 
study done by Daljith Singh et al, septic shock has got mortality of 
46.7%.63 
The most common infections of septic shock were  Acute CNS 
infection and pneumonia. Similarly respiratory infection was noted in the 
other study by Watson et al16, where as Jacob et al has reported meningitis 
as the most common cause of septic shock.68  Of the survived cases, 7 
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cases of septic shock had positive culture reports.of those seven cases,3 
cases grown Coagulase negative staphylococcus aureus,2cases grown 
Escherichia coli,1 grown Klebsiella species and other grown b-hemolytic 
streptococci. 
Cardiogenic shock was found to have mortality of 75% (6/8). The 
most common cause of cardiogenic shock in our study were  viral 
myocarditis and congenital heart diseases.. In Daljit Singh et al63 
Congenital heart disease was the most common cause of cardiogenic 
shock 53%. In a study by Chang P et al mortality was 75% in 
cardiogenicshock39 and cardiogenic shock due to myocarditis varied from 
2-37% in two studies.69,70 
The mortality due to acute rheumatic fever was 2% in a study by 
Majeed HA et al.71 The mortality of congenital heart disease patients 
admitted in ICU was 24.6% as reported by Kapil D et al. 
Hypovolemic shock had a least mortality in this study 7/34 
(20.58%), similar to that found in literature 0-20%.39,74,75 In a study done 
by Daljit Singh et al63 mortality due to hypovolemic shock was 2.3%. 
Acute gastroenteritis was the most common cause of hypovolemic shock 
in this study as was found in a study by Chang P et al39 and also according 
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to WHO which states acute diarrhoeal disease is one of the most common 
causes of mortality in children.19 
Temporal patterns of various clinical parameters showed significant 
differences in some parameters between survivors and non-survivors. The 
general trend is towards normalization of various physiological variables  
in survivors in the first 24-48hours. Where as the variables tended to be 
abnormal in non-survivors. 
GCS at admission was significantly low in non-survivors                         
(7.85±2.73) than in survivors (13.02±1.99), p value is statistically 
significant (<0.001). Similarly in study done by Raicevic R et al, level of 
consciousness was in positive correlation with outcome78, and GCS <8 
was an independent predictor of mortality in a new prognostic scoring 
system for meningococcal shock.79  
On admission, Heart rate (mean ± SD) – survivors (133.17 ± 
23.25), non-survivors (156.23 ± 34.02), p<0.001, which is statistically 
significant. 
There were more ventilated patients in the non-survivors (85.29%) 
than in survivors (6.3%) (p=0.001). Need for mechanical ventilation 
predicted mortality in shock cases because of two reasons 1) the need for 
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mechanical ventilation per se indicated the severity of shock 2) the 
multiple complications associated with ventilation which contribute to the 
mortality. The need for mechanical ventilation is found to be independent 
risk factor for mortality in this study. 
Hypoglycemia (blood glucose <50mg%) were noted in 11 cases. Out of 
them 10 cases survived and only 1 died.  
Abnormal renal function test were noted in 23 cases. Out of which septic 
shock constitutes 39.13% and hypovolemic shock constitute 30.43%.  
Compensated shock states were noted in 37 cases. Out of which all 
37(100%) survived.  Decompensated shock states were noted in 44 cases. 
Out of which only 10(22.72%) survived. 
In the compensated shocks states, a majority were noted in hypovolemic 
shock (56.75%). The decompensated shocks states, a majority were noted 
in septic shock (38.63%).  
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CONCLUSION 
 
1. A total of 81 cases who met the definition of shock among 7095 
patients admitted to the ward during the study period which 
constituted 1.14%  admissions. 
2. Majority of cases are in the age group of < 1 year (34.16% ). 
3. There was no significant difference in the  sex distribution in the 
survivors and non-survivors, while children among 6-10 years 
showed higher survival rate. 
4. Out of 81 cases of shock in this study, hypovolemic  
shock(41.97%) was the most common cause of shock  followed 
septic(27.16%) ,Dengue(20.98%) and cardiogenic shock(9.8%).The 
most common infection of septic shock were  pneumonia  and 
neuroinfection . The most common cause of cardiogenic shock 
were myocarditis and congenital heart disease and for hypovolemic 
shock was gastroenteritis. 
5. In this study overall mortality of shock was 41.97%. Septic shock 
has got highest mortality (68.18%) and hypovolemic shock  has got 
least mortality (20.58%). 
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6. Temporal patterns of various clinical parameters showed a trend 
towards normalization of the various physiological variables in 
survivors in the first 24-48 hours where as the variables tend to be 
abnormal in non-survivors. 
7. The clinical variables at admission which were significantly 
different between survivors and non survivors were: 
• GCS (mean±SD) – survivors (13.02±1.99), non-survivors 
(7.85±2.73), p value <0.001. 
• Heart rate (mean±SD) – survivors (133.17±23.25), non-survivors 
(156.23±34.02), p<0.001. 
There was increased need of mechanical ventilator in non-survivors 
(85.29%) as compared to survivors (6.3%), (p=0.001). 
Septic shock has got highest mortality (65.5%) followed by 
cardiogenic shock (31.0%) and hypovolemic shock has got least mortality 
(3.4%). 
The clinical variables at 24 hrs after admission, which were 
significantly different between survivors and non-survivors, were heart 
rate. Mean arterial blood pressure, capillary refilling time, core and 
peripheral temperature gradient and urine out put. 
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RECOMMENDATIONS 
• Continuous hemodynamic monitoring is essential in all cases of 
shock. Central venous pressure monitoring were not needed in all 
cases of shock at resource limited settings.   
• Early referral of cases diagnosed to have shock will improve the 
outcome.  
• Hypovolemic shock due to acute gastroenteritis is common. 
Measures to implement oral rehydration therapy should be 
intensified at primary health centres and sub centres. 
• Early goal directed therapy should be implemented in all cases. 
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LIMITATIONS 
• Markers of shock such as IL1, NO etc., were not done due to 
limited resources.  
• Co-morbid biochemical parameters such as hypoglycemia, 
dyselectrolemia, hyperlactemia and arterial blood gas analysis 
influencing mortality due to shock were not assessed.  
• Efficacy of bedside ultrasound abdomen, Echo, CVP Monitoring 
should be evaluated by further studies.  
CLINICAL PROFILE  OF  SHOCK IN  CHILDREN    AT    GRH
NAME AGE SEX I.P.NO D.O.A DIAGNOSIS HR RR BP SPO2 % GCS CRT URINE OUTPUT INOTROPES VENTILATION HB % TC DC SUGAR RFT BLOOD CULTURES OUTCOME TYPE SEVERITY
0hrs  12     24 0hrs  12     24 0hrs    24hrs 0hrs    24hrs 0hrs    24hrs
160  152   138 40  38   38 90/60      90/60 9/15  15/15 > 3 sec  < 3 sec
Karthick kumar
9  years male 84180
3/10/2009 scorpion sting ‐shock 130  126  120 32  30  28 90/60    100/70 92 12/15 15/15 >3 sec  <3 sec passed after  3 hrs NIL NIL 9.2 gms 10400 P52 L38   E5  M2 42 N NOTDONE SURVIVED
CARDIOGENIC  
SHOCK DECOMPENSATED
Nagaraj
2 years male 85603
8/10/2009 AGE  SHOCK 142  128  120 42  30  22 80/40   90/60 94 10/15 15/15 >3sec <3sec passed after  3 hrs NIL NIL 6.8 8600 P62 L34  E2  M2 82 ABNORMAL NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK COMPENSATED 
Afrin banu
46 days female 86210
11/10/2009 AGE  SHOCK 180  ‐   ‐ irregular NR NR 5/15     ‐‐‐‐‐‐‐‐ > 3 SEC NIL DOPAMINE 3 hrs for  3 hrs ‐ ‐ ‐ ‐ ‐ NOTDONE DIED
HYPOVOLEMIC 
SHOCK DECOMPENSATED
yogabharath 6 months male 87480 16/10/2009 meningitis ‐shock 176  ‐  ‐ shallow NR NR 6/15       ‐‐‐‐‐‐ >3 sec NIL DOP  5 HRS FOR 6 HRS ‐ ‐ ‐ ‐ ‐ NOTDONE DIED SEPTIC   SHOCK DECOMPENSATED
Thaswin 8 months male 88618 20/10/2009 acute CNS INF‐SHOCK 182  ‐  ‐ 30   ‐   ‐ 60/‐‐ NR 4/15 ‐‐‐‐‐‐‐‐‐‐ >3 sec NIL DOP  2 HRS FOR 3 HRS ‐ ‐ ‐ ‐ ‐ NOTDONE DIED SEPTIC   SHOCK DECOMPENSATED
Gayathri
9 years female 92462
28/10/2009 DKA   SHOCK 140  150   ‐ 42  ‐  ‐ 90/40    ‐‐‐‐ 86 10/15  ‐‐‐‐‐ > 3SEC NIL DOP 10 HRS for  3 hrs ‐ ‐ ‐ 380 ABNORMAL NOTDONE DIED
HYPOVOLEMIC 
SHOCK DECOMPENSATED
Iswarya
2 months female 92391
3/11/2009 AGE  SHOCK 183  160   120 38   36   36 60 /‐‐      80/60 82        92 12/15   14/15 >3 SEC < 3SEC passed after  3 hrs ‐ ‐ 9.2 7600 P54 L42 E 4 60 ABNORMAL NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK DECOMPENSATED
Rabecca
2months  female 93309
6/11/2009 myocarditis ‐shock 202  ‐     ‐ unstable NR NR 4/15  ‐‐‐‐‐‐‐ >3sec <3sec NIL DOP  12 HRS FOR 10 HRS ‐ ‐ ‐ 66 ABNORMAL NOTDONE DIED
CARDIOGENIC  
SHOCK DECOMPENSATED
Soundarya 5 years female 93473 7/11/2009 DENGUE ‐SHOCK 80    100   96 24   22   20 80/40  90/60 92 13/15  15/15 >3sec <3sec passed after  3 hrs ‐ ‐ 8.4 5400 P36 L52 E2 M1 60 ABNORMAL NOTDONE SURVIVED DENGUE   SHOCK COMPENSATED 
Prisilla 8 months  female 93984 9/11/2009 septic shock 170   ‐    ‐ gasping NR NR 4/15   ‐‐‐‐‐‐ >3 SEC NIL DOP 45 MIN FOR 30MIN ‐ ‐ ‐ ‐ ‐ NOTDONE DIED SEPTIC   SHOCK DECOMPENSATED
Deepika 2 1/2 years female 93985 11/11/2009 DENGUE ‐SHOCK 108   ‐    ‐ 28   24    ‐ 60/40  ‐‐‐‐‐ 90 12/15   ‐‐‐‐‐ >3 SEC   NIL  DOP  10 HRS ‐ ‐ ‐ ‐ 68 ABNORMAL NOTDONE DIED DENGUE   SHOCK DECOMPENSATED
Gopika 3 years female 95026 13/11/2009 DENGUE ‐SHOCK 140   120   118 32   30 26 90/40      90/60 94 13/15  15/15 >3sec <3sec PASSED  AFTER 4 HRS ‐ ‐ 10.2 7200 P38 L52 E3M2 80 NORMAL NOTDONE SURVIVED DENGUE   SHOCK COMPENSATED 
Karpoora sundar 2 1/2 years male 97951 24/11/2009 DENGUE ‐SHOCK 72   82    90 30   ‐     ‐ NR NR 9/15   ‐‐‐‐‐ >3 SEC<3SEC NL DOP 45 MIN FOR 45 MIN ‐ ‐ ‐ ‐ ‐ NOTDONE DIED DENGUE   SHOCK DECOMPENSATED
Tharunpandi 2 years male 100020 1/12/2009 AGE SEPSIS SHOCK 138   ‐   ‐ 32   ‐   ‐ NR NR 12/15  ‐‐‐‐‐ >3 SEC  NIL DOP 4 HRS for  3 hrs ‐ ‐ ‐ ‐ ‐ NOTDONE DIED SEPTIC   SHOCK DECOMPENSATED
Meena 5 years female 101528 5/12/2009 DENGUE ‐SHOCK 100   108   110 30   28   20 90/40    100/60 90 13/15 15/15 >3sec <3sec passed after  3 hrs ‐ ‐ 7.8 7500 P52 L38   E5  M2 70 N NOTDONE SURVIVED DENGUE   SHOCK DECOMPENSATED
Gayathri 10months female 102759 9/12/2009 DENGUE ‐SHOCK 90   110   108 42   38   30 80/60     80/60 92 10/15    12/15 >3sec <3sec PASSED AFTER 5 HRS DOP FOR 24 HRS ‐ 8.2 8600 P40 L58 E1M0 80 N NOT DONE SURVIVED DENGUE   SHOCK DECOMPENSATED
Shanmuga priya 50 days  female 103037 12/12/2009 septic shock 160   152     148 32   30   30 80/60     80/60 94 10/15  14/15 >3sec <3sec PASSED AFTER 4 HRS DOP FOR 30 HRS ‐ 7.2 10800 P62 L34  E2  M2 72 ABNORMAL KLEBSIELLA  SPECIES + SURVIVED SEPTIC   SHOCK COMPENSATED 
palaniswmy 6 years male 103289 13/12/2009 DENGUE ‐SHOCK 120  116   112 28   26   28 100/60  100/60 98 13/15  15/15 >3sec <3sec PASSEDAFTER 6 HRS ‐ ‐ 10.2 10600 P66 L28 E3 60 NORMAL NOTDONE SURVIVED DENGUE   SHOCK COMPENSATED 
hariharan 7 YEARS male 103511 14/12/2009 DENGUE ‐SHOCK 80   60   100 24   22    24 100/60   110/70 92 13/15  15/15 >3sec <3sec PASSEDAFTER 3 HRS ‐ ‐ 9.6 7200 P38 L60 E3 54 NORMAL NOTDONE SURVIVED DENGUE   SHOCK COMPENSATED 
B/O  lakshmi 44 days male 103877 15/12/2009 septic shock 160   ‐    ‐ 42    ‐     ‐ NR NR 8/15  ‐‐‐‐‐ >5 SEC  ‐‐‐‐ NIL DOP FOR 2 HRS FOR 3 HRS ‐ ‐ ‐ ‐ ‐ NOTDONE DIED SEPTIC   SHOCK DECOMPENSATED
Gowtham 1 3/4 year male 105125 20/12/2009 septic shock 152   132   128 40   38   36 60/40   70/50 90 9/15   15/15 >3 SEC < 3SEC PASSED AFTER 3 HRS DOP FOR 6 HRS ‐ 9.8 8400 P60  L36  E2  M2 42 N E.COLI   GROWN SURVIVED SEPTIC   SHOCK COMPENSATED 
Arokiyaraj 2 1/2years m male 107524 30/12/2009 septic shock 180    ‐    ‐ 42    ‐     ‐ NR NR 5/15  ‐‐‐‐‐ >3SEC ‐‐‐‐‐ NIL DOP FOR 4 HRS FOR 2 HRS ‐ ‐ ‐ ‐ ‐ NOTDONE DIED SEPTIC   SHOCK DECOMPENSATED
meenakshi
5 months female 599
3/1/2010 age  shock seizures 160    ‐     ‐ gasping NR NR 8/15     9/15 >3sec <3sec NIL DOP FOR 1 HRS FOR 1 HRS ‐ ‐ ‐ ‐ ‐ NOTDONE DIED
HYPOVOLEMIC 
SHOCK DECOMPENSATED
Rooban  vijay
1 1/4 years male 1557
6/1/2010 AGE SHOCK 186    ‐    ‐ 48   ‐     ‐ 60/‐     ‐‐‐‐ NR 9/15   ‐‐‐‐‐ >3SEC  ‐‐‐‐‐ NIL DOP FOR 12HRS FOR2 HRS ‐ ‐ ‐ ‐ ‐ NOTDONE DIED
HYPOVOLEMIC 
SHOCK DECOMPENSATED
Karthiga
12 years female 2916
12/1/2010 CRF  SHOCK 130   140   132 40   38   42 80/60     90/60 NR 10/15   ‐‐‐‐‐ >3SEC‐‐‐‐‐‐ NIL DOP FOR 20 HRS FOR 3 HRS 6.4 7600 P56 L38 E 2 50 ABNORMAL NOTDONE DIED
CARDIOGENIC  
SHOCK DECOMPENSATED
VELAVAN 3 years male 3375 14/1/2010 septic shock 142    128   132 42    36   38 60/40    70/50 86 10/15     13/15 >3SEC PASSED AFTER 8 HRS DOP FOR  48 HRS FOR 4 HRS 8.2 5400 P62 L34  E2  M2 62 ABNORMAL CONS GROWN DIED SEPTIC   SHOCK DECOMPENSATED
Muneeshwaran 9 months male 4152 17/1/2010 septic shock 160   132   140 36   32    34 NR NR 8/15  9/15 >3SEC ‐‐‐‐‐ NIL DOP FOR 48 HRS FOR 8 HRS 9 18,200 P80L20 52 ABNORMAL NOTDONE DIED SEPTIC   SHOCK DECOMPENSATED
nithya 8 years female 5158 21/1/2010 DENGUE ‐SHOCK 102   110   108 32    30   32 100/70   100/70 92 14/15    15/15 >3sec <3sec passed after  3 hrs ‐ ‐ 10 8200 P46 L48 E2 50 N NOTDONE SURVIVED DENGUE   SHOCK COMPENSATED 
Kaleeshwari
8 years female 6321
25/1/2010 AGE SHOCK 128    118   120 28   26    24 110/70    110/70 92 15/15   15/15 >3sec <3sec PASSED AFTER 2 HRS ‐ ‐ 8.2 9600 p68 L26 E2 62 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK COMPENSATED 
Shobana
12 years female 6638
27/1/2010 RHD  SHOCK 130    120     122 38   38    32 130/80   120/70 99 15/15  15/15 >3sec <3sec PASSED AFTER 3 HRS DOP FOR 5 HRS FOR 5 HRS 9 10200 P40 L58 E1M0 70 N  NOTDONE SURVIVED
CARDIOGENIC  
SHOCK COMPENSATED 
Sivakumar
7 years  male 11200
1/2/2010 AGE  SHOCK 130   128    120 42   38    32 110/70  110/70 92 15/15   15/15 >3sec <3sec PASSED AFTER 3 HRS ‐ ‐ 8.6 7200 P46L52 E 2 62 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK COMPENSATED 
Lekhasree
1 1/2 year female 12600
19/2/2010 kerosene pois shock 160    150    140 42    38     30 NR NR 10/15  ‐‐‐‐‐‐ >3SEC  ‐‐‐‐‐ NIL DOP FOR 4 HRS FOR 4 HRS 9.2 8600 P42 L56 E2 70 ABNORMAL NOTDONE DIED
HYPOVOLEMIC 
SHOCK DECOMPENSATED
Nagapandi 2 1/2 years male 19104 18/3/2010 septic shock 162    ‐     ‐ 46    ‐     ‐ 60 /‐ 90 13/15  ‐‐‐‐ >3SEC  ‐‐‐‐‐ NIL DOPFOR 5 HRS FOR 2HRS 8.6 8200 P60  L36  E2  M2 82 ABNORMAL NOTDONE DIED SEPTIC   SHOCK DECOMPENSATED
Tharunya 6 years  female 19664 20/3/2010 empyema  shock 140    ‐     ‐ 42    ‐     ‐ 100/60    ‐‐‐‐‐ 96 15/15 >3SEC  <3SEC passed after  3 hrs DOP FOR 24 HRS ‐ 9 10800 P72 L28 56 ABNORMAL NOTDONE SURVIVED SEPTIC   SHOCK COMPENSATED 
Shobika 33 days female 22568 30/3/2010 septic shock 138   ‐     ‐ 30    ‐    ‐ NR NR 10/15  ‐‐‐‐ >4SEC  ‐‐‐‐ NIL DOPFOR 5 HRS FOR 2 HRS ‐ ‐ ‐ ‐ ‐ NOTDONE DIED SEPTIC   SHOCK DECOMPENSATED
B/O Palaniselvi 2 1/2 month male 23298 2/4/2010 septic shock 160    ‐    ‐ 32   ‐    ‐ NR NR 3/15   ‐‐‐‐ >4 SEC  ‐‐‐ NIL DOP FOR1 HR FOR 1HR ‐ ‐ ‐ ‐ ‐ NOTDONE DIED SEPTIC   SHOCK DECOMPENSATED
Ritsen
1 year male 24621
7/4/2010 AGE  SHOCK 168   156   140 38    32    34 90/60   90/60 96 15/15 >3SEC  <3SEC passed after 3 hrs ‐ ‐ 9.2 9200 p48 L46 E2 42 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK COMPENSATED 
Arunadevi 9 years female 25349 10/4/2010 DENGUE ‐SHOCK 142   140     130 40    30   28 100/60   110/70 96    96 15/15  15/15 >3sec <3sec PASSED AFTER 2 HRS ‐ ‐ 10.4 10200 P42 L56 E2 60 N NOTDONE SURVIVED DENGUE   SHOCK COMPENSATED 
Aravindh
6 years male 27074
16/4/2010 AGE  SHOCK 132   134   130 30   26   20 100/60   100/60 96   96 15/15   15/15 >3sec <3sec PASSED AFTER 3 HRS ‐ ‐ 6.8 9420 P51 L36 E3 80 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK COMPENSATED 
Rajkumar
7 years male 28297
21/4/2010 AGE SHOCK 128   120   116 30   32    30 100/60   100/70 98   98 15/15   15/15 >3sec <3sec PASSEDAFTER 2 HRS ‐ ‐ 9.8 11200 P80 L18 E2 112 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK COMPENSATED 
Sanchana 7 mon female 29363 25/4/2010 septic shock 164   ‐    ‐ 32    ‐    ‐ NR NR 6/15   ‐‐‐‐ >3SEC NIL DOP FOR 6 HRS ‐ ‐ ‐ ‐ ‐ ‐ NOT DONE DIED SEPTIC   SHOCK DECOMPENSATED
Kani
8 years male 32294
2/5/2010 AGE  SHOCK 132   130   130 28    24   20 90/50    100/60 92     98 13/15    15/15 >3sec <3sec PASSED AFTER5 HRS ‐ ‐ 10.6 8600 P28 L72 E2 116 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK DECOMPENSATED
Mahalaxmi
4 years female 36394
9/5/2010 AGE SHOCK 140    128   110 30    28   20 90/60     100/60 96     98 12/15    15/15 >3SEC  <3SEC PASSEDAFTER 4 HRS ‐ ‐ 8.2 12400 P32L64E2M2 24 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK DECOMPENSATED
Vetrivel
7 months male 38313
12/5/2010 AGE  SHOCK 162    ‐      ‐ 40     ‐    ‐ NR NR 5/15 ‐‐‐‐‐‐‐‐ >4 SEC  ‐‐‐ NIL DOP FOR 10 HRS FOR 6 HRS ‐ ‐ ‐ ‐ ‐ NOTDONE DIED
HYPOVOLEMIC 
SHOCK DECOMPENSATED
Devipriya
1 1/2 year f female 38782
24/5/2010 AGE SHOCK 124    120   118 30   24   20 100/60 100/60 92    96 15/15   15/15 >3sec <3sec PASSEDAFTER4 HRS ‐ ‐ 10.2 12800 P40 L58 E1M0 80 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK COMPENSATED 
PRIYADHARSINI
8 years female 41167
2/6/2010 AGE  SHOCK 134    120     108 33    27    28 100/60  100/60 98   98 14/15  15.15 >3sec <3sec PASSEDAFTER3 HRS ‐ ‐ 6.8 10200 P28 L72 E2 60 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK COMPENSATED 
Velmani 5 years male 41924 4/6/2010 meningitis  shock 140   132   120 42   36     30 90/60     100/70 92   94 13/15  15/15 >3sec <3sec PASSEDAFTER1 HRS ‐ FOR 6 HRS 9.2 8600 P62 L34  E2  M2 62 ABNORMAL CONS GROWN SURVIVED SEPTIC   SHOCK COMPENSATED 
Muthuselvam
1 1/2 year male 43047
8/6/2010 AGE SHOCK 128    126   120 40   32    28 90/60     90/60 90   92 14/15   15/15 >3sec <3sec PASSEDAFTER 3 HRS ‐ ‐ 8.6 6800 P72L34E2M2 48 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK COMPENSATED 
B/O Varghese
40  days female 46283
20/6/2010 AGE SHOCK 160   152   148 32   30   28 80/60      80/60 94    96 13/15  15/15 >3sec <3sec PASSED AFTER2 HRS ‐ ‐ 9 7800 p68 L26 E2 50 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK COMPENSATED 
Kavyashree
4 months female 46878
22/6/2010 myocarditis ‐shock 208    ‐     ‐ 48    ‐    ‐ NR NR 5/15 ‐‐‐‐‐ >4SEC  ‐‐‐‐ NIL DOPFOR 3HRS FOR 2 HRS ‐ ‐ ‐ ‐ ‐ NOTDONE DIED
CARDIOGENIC  
SHOCK DECOMPENSATED
Mahalaxmi
40 days female 47513
25/6/2010 AGE  SHOCK 168    154  140 42   38   30 80/60   80/60 92   94 13/15 >3sec <3sec PASSED AFTER 1HR ‐ ‐ 10.2 5600 p68 L26 E2 42 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK COMPENSATED 
Nagaraj 4 years male 48236 27/6/2010 DENGUE ‐SHOCK 142    ‐     ‐ 32    ‐    ‐ 90/60    90/60 86 12/15 ‐‐‐ >3SEC  ‐‐‐‐‐ NIL DOP FOR 1 HRS FOR 1 HRS ‐ ‐ ‐ ‐ ‐ NOTDONE DIED DENGUE   SHOCK DECOMPENSATED
KISHORE
2 years male 48803
29/6/2010 AGE SHOCK 150   142   138 38  35   30 90/60     90/60 92  94 14/15    15/15 >3SEC   <3SEC PASSED AFTER 4 HRS ‐ ‐ 8.2 6800 P78L30E2 46 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK COMPENSATED 
Nithyarupa
6 years female 48859
29/6/2010 AGE SHOCK 138   136    130 32   28     22 100/70    100/70 94   96 14/15   15/15 >3sec <3sec PASSEDAFTER 2 HRS ‐ ‐ 9.6 5600 P68L32 E2 62 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK COMPENSATED 
Anand
11 years male 50090
4/7/2010 AGE  SHOCK 120   118  116 26    22   20 100/70   100/70 92    96 14/15   15/15 >3sec <3sec PASSEDAFTER 4 HRS ‐ ‐ 10.2 8400 P72 L36 E2 58 ABNORMAL NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK COMPENSATED 
B/O Anish 30days female 50136 4/7/2010 septic shock 160   140   138 32   30    28 NR NR 5/15   ‐‐‐ >4SEC  ‐‐‐‐ NIL DOP FOR 48 HRS FOR 4 HRS 6.2 10200 P86L12 E2 40 ABNORMAL E.COLI   GROWN DIED SEPTIC   SHOCK DECOMPENSATED
jeyaram
6 months male 84365
4/10/2009 AGE  SHOCK 92    passed  after 6 hrs NIL NIL 8 gms 8600 COMPENSATED P60  L36  E2  M2 56 N NOT DONE SURVIVED
HYPOVOLEMIC 
SHOCK
Karupasamy
2 1/2years m male 50142
4/7/2010 AGE SHOCK 152   150    130 38   30   22 90/60   90/60   92    96 13/15    15/15 >3SEC <3SEC PASSEDAFTER 2 HRS ‐ ‐ 8.6 7600 P78L26E2 M2 60 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK COMPENSATED 
Narmatha
8 years female 51024
7/7/2010 AGE  SHOCK 118   110   102 30   24    20 100/70    100/70 92    94 14/15   15/15 > 3 sec  < 3 sec PASSEDAFTER 3 HRS ‐ ‐ 9.2 10800 P64L32 E2 62 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK COMPENSATED 
Kaviyarasan 7 months male 104146 16/12/2009 DENGUE ‐SHOCK 88    100     102 18    16     16 90/60     90/60 96    96 15/15   15/15 >3sec <3sec PASSED AFTER 2 HRS ‐ ‐ 10 8200 P52 L46 E2 62 N NOTDONE SURVIVED DENGUE   SHOCK COMPENSATED 
Karuppuraja
10 year  male 53859
17/7/2010 AGE SHOCK 122    120   110 22    20  18 100/70   100/70 92    96 15/15   15/15 >3sec <3sec PASSED AFTER 4 HRS ‐ ‐ 8.2 6400 P72 L26 E2 54 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK COMPENSATED 
Selvakumar
4 months male 53950
18/7/2010 AGE  SHOCK 148   128   110 30   24   22 90/60    90/60 96     98 14/15  15/15 >3sec <3sec PASSEDAFTER 5 HRS ‐ ‐ 9.6 10200 P64L32 E2 50 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK COMPENSATED 
Deepak 10 months male 53932 18/7/2010 septic shock 160   132   112  28   20   20 90/60  90/60 92   93 13/15 14/15 >3sec <3sec PASSED AFTER 2 HRS ‐ ‐ 8.2 9200 P58L40 E2 62 N NOTDONE SURVIVED SEPTIC   SHOCK COMPENSATED 
Somasundaram
10 years male 54974
22/7/2010 AGE  SHOCK 122     120   116 24    16   18 100/70   100/70 94     94 15/15    15/15 >3sec <3sec PASSED AFTER 3 HRS ‐ ‐ 9.2 8600 P60  L36  E2  M2 68 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK COMPENSATED 
Rajasekar 2 years male 57478 29/7/2010 septic shock 142     ‐‐      ‐‐ 42    ‐‐     ‐‐ NR NR 6/15 ‐‐‐‐‐‐‐ >4SEC  ‐‐‐‐ NIL DOP FOR 4 HRS FOR 4 HRS ‐ ‐ ‐ ‐ ‐ NOTDONE DIED SEPTIC   SHOCK DECOMPENSATED
Oviya 10 years female 58191 13/8/2010 DENGUE ‐SHOCK 130   126   128 40    42    38 100/60   100/60 92     96 14/15     15/15 >3sec <3sec PASSEDAFTER5 HRS ‐ ‐ 10.2 7600 P70L28E2 80 N NOTDONE SURVIVED DENGUE   SHOCK COMPENSATED 
Sumathi
12 years female 60078
8/8/2010 AGE  SHOCK 128   124    120 42    36   30 100/70   100/70 94     96 15/15     15/15 >3sec <3sec PASSEDAFTER2HRS ‐ ‐ 9.6 8200 P42 L56 E2 62 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK DECOMPENSATED
Yalini 8 years female 65584 29/8/2010 DENGUE ‐SHOCK 90     ‐‐     ‐‐‐ 40    ‐‐    ‐‐ NR NR 8/15     ‐‐‐‐ >4SEC  ‐‐‐‐ NIL ‐ ‐ ‐ ‐ ‐ ‐ ‐ NOTDONE DIED DENGUE   SHOCK DECOMPENSATED
Lathigasri 3 years  female 65610 29/8/2010 DENGUE ‐SHOCK 94      108     92 40    38    48 6O/‐     60/‐ 86        88 10/15     8/15 >3SEC  >3SEC PASSED AFTER4 HRS DOP FOR 24 HRS FOR 20 HRS 10.2 7800 p48 L46 E2 72 ABNORMAL NOTDONE DIED DENGUE   SHOCK DECOMPENSATED
Gokulnath 36 DAYS male 66582 1/9/2010 septic shock 180    ‐‐‐      ‐‐ 58   ‐‐      ‐‐ NR        NR NR 8/15 ‐‐‐ >3SEC‐‐‐‐‐‐ NIL DOP FOR 10 HRS FOR 2 HRS ‐ ‐ ‐ ‐ ‐ NOTDONE DIED SEPTIC   SHOCK DECOMPENSATED
Durgadevi
5 years female 66974
3/9/2010 AGE  SHOCK 120     110    108 36    29     24 100/60    100/60 92     98 13/15    15/15 .3SEC  <3SEC PASSED AFTER 3 HRS ‐ ‐ 8.8 10600 P63 L36 E2 83 N NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK COMPENSATED 
Maheshwari
7 months female 68073
8/9/2010 AGE  SHOCK SEIZURES 140    ‐‐‐     ‐‐‐ 48    ‐‐‐     ‐‐ NR NR 5/15 ‐‐‐‐‐ >3SEC‐‐‐‐‐‐ NIL DOP   FOR 3 HRS ‐ ‐ ‐ ‐ ‐ ‐ NOTDONE DIED
HYPOVOLEMIC 
SHOCK DECOMPENSATED
Saravanan
5months male 68417
10/9/2010 myocarditis ‐shock 206    ‐‐‐‐     ‐‐‐ 58   ‐‐‐    ‐‐ 60/‐      ‐‐‐‐ 84    ‐‐‐ 10/15 ‐‐‐‐ >4SEC  ‐‐‐‐ PASSEDAFTER 4 HRS DOP FOR 4 HRS FOR 4 HRS ‐ ‐ ‐ ‐ ABNORMAL NOTDONE DIED
CARDIOGENIC  
SHOCK DECOMPENSATED
Ranjithkumar 6 years male 69187 14/9/2010 DENGUE ‐SHOCK 120    118    102 38   32    28 100/60    100/60 92     94 14/15   15/15 >3sec <3sec PASSED AFTER3 HRS ‐ ‐ 7.2 7300 P62 L34  E2  M2 47 N NOTDONE SURVIVED DENGUE   SHOCK COMPENSATED 
Abhinesh
9 months male 70228
18/9/2010 AGE   SHOCK 140     132     11656    42    30 70/‐       90 /60 84    97 10/15    15/15 >3sec <3sec PASEEDAFTER2HRS ‐ ‐ 9.4 9400 P38 L60 E3 63 ABNORMAL NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK DECOMPENSATED
Pandi
2 1/2 years male 70511
19/9/2010 septic shock 180    170    150 62    56    52 NR  90/60 NR     92 8/15    14/15 >3SEC<3sec passed after  3 hrs DOP FOR 24 HRS ‐ 8.2 8000 P64L32 E2 60 ABNORMAL
b hemolytic streptococci 
grown SURVIVED SEPTIC   SHOCK DECOMPENSATED
Divya
8 years female 70767
20/9/2010 AGE  SHOCK 120       112   10240   34     26 90/60      100/60 86      96 10/15   15/15 >3sec <3sec passed after 4 hrs ‐ ‐ 9.6 9600 p64l36 63 ABNORMAL NOTDONE SURVIVED
HYPOVOLEMIC 
SHOCK DECOMPENSATED
Yogasri
23/4 year female 71188
22/9/2010 cardiomyopathy  shock 200   180    ‐‐‐ 50     52     ‐‐ NR NR 10/15   15/15 >3sec <3sec NIL DOPFOR 6 HRS FOR 4 HRS ‐ ‐ ‐ ‐ ‐ NOTDONE DIED
CARDIOGENIC  
SHOCK DECOMPENSATED
Riswan banu
10 months female 72024
26/9/2010 myocarditis ‐shock 208     ‐‐‐      ‐‐‐ 60   ‐‐      ‐‐ 60/‐    ‐‐‐‐‐ 84 9/15 ‐‐‐‐ >3 SEC ‐‐‐ NIL DOP FOR6HRS FOR 4 HRS ‐ ‐ ‐ ‐ ‐ NOTDONE DIED
CARDIOGENIC  
SHOCK DECOMPENSATED
Hasini 11/4year female 72105 28/9/2010 acute CNS INF‐SHOCK 140    130    118 42     38     28 60/‐    90/60 84     94 9/15   14/15 >3SEC  <3SEC PASSED AFTER 5 HRS DOP FOR 12HRS FOR 2 HRS 9.2 10450 p48 L46 E2 84 ABNORMAL CONS GROWN SURVIVED SEPTIC   SHOCK DECOMPENSATED
Papammal 11 years female 72982 30/9/2010 ALL DENGUE SOCK 110     ‐‐‐      ‐‐‐ 32    ‐‐‐       ‐‐ NR NR 8/15     ‐‐‐ >3SEC ‐‐‐‐‐ NIL DOP FOR 4 HRS FOR2 HRS ‐ ‐ ‐ 80 ABNORMAL NOT DONE DIED DENGUE   SHOCK DECOMPENSATED
DENGUE SHOCK SYNDROME 
 
SCORPION STING – CARDIOGENIC SHOCK 
 
PEM ‐ SEPTIC SHOCK 
 
